SS31 therapy effectively protects the heart against transverse aortic constriction-induced hypertrophic cardiomyopathy damage.
In conclusion, SS31 therapy effectively protected the heart against TAC-induced damage.
PMID: 29312478 [PubMed]
Source: American Journal of Translational Research - Category: Research Tags: Am J Transl Res Source Type: research
More News: Antidoxidants | Cardiology | Cardiomyopathy | Heart | Hypertrophic Cardiomyopathy | Research | Study